<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
Close
Contact UsLanguageSearch
Background Image

Our Company

Headquartered in California, US, Crown Bioscience is a global contract research organization (CRO) providing discovery, preclinical and translational platforms and services to advance oncology and immuno-oncology.

We are known for our high-quality and expansive in vivo, in vitro, and ex vivo preclinical models, and partner with our clients to quantify the efficacy and pharmacological profile of their drug candidate(s) before they move into the clinic. We aim to deliver superior drug candidates to ensure that patients get the right treatment at the right time.

Our Mission

Our mission is to empower our customers to improve human health.

We do this by engaging the finest scientific talent, upholding the highest quality standards, and relentlessly pursuing innovation.

Every day we strive to accelerate and de-risk drug development to help realize a world where every patient gets the right treatment, at the right time.

Our Vision

Together we can realize a world where every patient gets the right treatment, at the right time.

  1. 2006

    Crown Bioscience Inc. founded

  2. 2007
    Oncology Platform Established
  3. 2008
    Biologics platform established

    New R&D Centre founded in Taicang, China

  4. 2009

    Crown Bioscience US R&D site founded

  5. 2013

    Acquisition of PRECOS Ltd. (Now Crown Bioscience UK)

  6. 2013
    Bioluminescence Imaging platform established
  7. 2014

    Crown Bioscience Taiwan founded

  8. 2015

    Expansion of Western PDX Models

  9. 2017

    Acquisition of Molecular Response (Now Crown Bioscience San Diego, US)

  10. 2017
    Inflammation Platform Established
  11. 2017

    Expansion of UK & US Oncology Facilities

  12. 2018

    Expansion of Bioinformatics Facilities, Suzhou, China

  13. 2018

    Acquisition by JSR Corporation

  14. 2019
    Organoid Platform Established
  15. 2020

    Expansion of China Oncology Facilities in Zhongshan

  16. 2020

    Crown Bioscience Netherlands organoid center founded

  17. 2021

    Acquisition of OcellO B.V. Expansion of in vitro capability

  18. 2022

    Crown Bioscience & MBL Joint Venture Established in Japan

  19. 2023

    Acquisition of Indivumed Services

 

Our Brand

 


About JSR Life Sciences

JSR Life SciencesCrown Bioscience is a division of JSR Life Sciences, part of the multinational JSR Corporation.

JSR Life Sciences provides specialized technology, products, materials, and services to biopharmaceutical companies and life science researchers.

Through the service offerings of our affiliates, including Crown Bioscience, JSR has created a framework that provides a fully integrated drug development process, from discovery through commercial production, that accelerates development timelines and can increase clinical success rates.

Crown Bioscience is a global contract research organization (CRO) providing discovery, preclinical, and translational platforms to advance oncology and immuno-oncology.

Learn More

MBL implements biomarker discovery for companion diagnostics, and the development and manufacturing of in vitro diagnostics (IVDS) for immunological and genetic testing.

Learn More


KBI Biopharma provides deep analytical services, process development, and GMP manufacturing for clinical trials and commercialization of biopharmaceuticals.

Learn More